{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:19:06Z","timestamp":1789885146500,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1001757"],"award-info":[{"award-number":["G1001757"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002992","name":"Department for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/mt.2016.3","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T07:20:09Z","timestamp":1452237609000},"page":"832-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection"],"prefix":"10.1016","volume":"24","author":[{"given":"Beatrice","family":"Ondondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Murakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Clutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Abdul-Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund G-T","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"McMichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette","family":"Korber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.3_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/14712598.2014.885946","article-title":"Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines","volume":"14","author":"Hanke","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/mt.2016.3_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ni.2264","article-title":"Lessons learned from HIV-1 vaccine trials: new priorities and directions","volume":"13","author":"McMichael","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1038\/mt.2016.3_bib3","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science"},{"key":"10.1038\/mt.2016.3_bib4","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.1073\/pnas.1501443112","article-title":"Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial","volume":"112","author":"Kuebler","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2016.3_bib5","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1128\/JVI.00437-12","article-title":"Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted\/founder virus replication","volume":"86","author":"Freel","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.3_bib6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"Goonetilleke","year":"2009","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2016.3_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.1143767","article-title":"A whole-genome association study of major determinants for host control of HIV-1","volume":"317","author":"Fellay","year":"2007","journal-title":"Science"},{"key":"10.1038\/mt.2016.3_bib8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature12893","article-title":"Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV","volume":"505","author":"Roederer","year":"2014","journal-title":"Nature"},{"key":"10.1038\/mt.2016.3_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2016.3_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1038\/mt.2016.3_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants","volume":"13","author":"Fischer","year":"2007","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.3_bib12","article-title":"Increased valency of conserved-mosaic vaccines enhances the breadth and depth of epitope recognition","author":"Abdul-Jawad","year":"2015","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.3_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.3_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm.2108","article-title":"Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys","volume":"16","author":"Santra","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.3_bib15","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","volume":"2","author":"L\u00e9tourneau","year":"2007","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.3_bib16","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.ppat.0030157","article-title":"HIV-1 group M conserved elements vaccine","volume":"3","author":"Rolland","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2016.3_bib17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/JVI.02370-14","article-title":"Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance","volume":"89","author":"Yang","year":"2015","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.3_bib18","doi-asserted-by":"crossref","first-page":"1254031","DOI":"10.1126\/science.1254031","article-title":"HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck","volume":"345","author":"Carlson","year":"2014","journal-title":"Science"},{"key":"10.1038\/mt.2016.3_bib19","doi-asserted-by":"crossref","first-page":"E1480","DOI":"10.1073\/pnas.1421607112","article-title":"Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression","volume":"112","author":"Claiborne","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2016.3_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature"},{"key":"10.1038\/mt.2016.3_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.immuni.2012.11.022","article-title":"Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design","volume":"38","author":"Ferguson","year":"2013","journal-title":"Immunity"},{"key":"10.1038\/mt.2016.3_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.12.021","article-title":"Control of HIV-1 replication by vaccine-induced CD8+ T cells in humans through conserved subdominant non-Gag epitopes","author":"Ahmed","year":"2016","journal-title":"Vaccine"},{"key":"10.1038\/mt.2016.3_bib23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.3_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/1479-5876-9-208","article-title":"Definition of the viral targets of protective HIV-1-specific T cell responses","volume":"9","author":"Mothe","year":"2011","journal-title":"J Transl Med"},{"key":"10.1038\/mt.2016.3_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12967-015-0392-5","article-title":"A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques","volume":"13","author":"Mothe","year":"2015","journal-title":"J Transl Med"},{"key":"10.1038\/mt.2016.3_bib26","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.3_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.3_bib28","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/JVI.78.7.3233-3243.2004","article-title":"Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load","volume":"78","author":"Masemola","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.3_bib29","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1371\/journal.pone.0001424","article-title":"Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads","volume":"3","author":"Rolland","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.3_bib30","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/JVI.80.6.3122-3125.2006","article-title":"Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control","volume":"80","author":"Zu\u00f1iga","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.3_bib31","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1073\/pnas.90.15.7176","article-title":"Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis","volume":"90","author":"Korber","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2016.3_bib32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.171.2.571","article-title":"An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself","volume":"171","author":"Takahashi","year":"1990","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2016.3_bib33","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/CVI.00587-14","article-title":"Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB\/c mice","volume":"21","author":"Ondondo","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1038\/mt.2016.3_bib34","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.1128\/JVI.00689-12","article-title":"HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent","volume":"86","author":"Naruto","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.3_bib35","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JVI.03627-14","article-title":"Early kinetics of the HLA class I-associated peptidome of MVA.HIVconsv-infected cells","volume":"89","author":"Ternette","year":"2015","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.3_bib36","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1128\/JVI.00020-15","article-title":"Clinical control of HIV-1 by cytotoxic T cells specific for multiple conserved epitopes","volume":"89","author":"Murakoshi","year":"2015","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.3_bib37","doi-asserted-by":"crossref","first-page":"e1004658","DOI":"10.1371\/journal.ppat.1004658","article-title":"Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses","volume":"11","author":"Hancock","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2016.3_bib38","doi-asserted-by":"crossref","first-page":"e20479","DOI":"10.1371\/journal.pone.0020479","article-title":"Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.3_bib39","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/mt.2016.3_bib40","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2016.3_bib41","first-page":"380","article-title":"Vertical T cell immunodominance and epitope entropy determine HIV-1 escape","volume":"123","author":"Liu","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.3_bib42","first-page":"e52610","article-title":"Pairwise growth competition assay for determining the replication fitness of human immunodeficiency viruses","volume":"4","author":"Manocheewa","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1038\/mt.2016.3_bib43","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.3390\/v7112901","article-title":"Composite sequence-structure stability models as screening tools for identifying vulnerable targets for HIV drug and vaccine development","volume":"7","author":"Manocheewa","year":"2015","journal-title":"Viruses"},{"key":"10.1038\/mt.2016.3_bib44","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1128\/JVI.03033-12","article-title":"HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity","volume":"87","author":"Rolland","year":"2013","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.3_bib45","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"Ewer","year":"2013","journal-title":"Nat Commun"},{"key":"10.1038\/mt.2016.3_bib46","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/mt.2011.176","article-title":"Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors","volume":"19","author":"Sheehy","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.3_bib47","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/COH.0b013e32835ef089","article-title":"Combined approaches for HIV cure","volume":"8","author":"Margolis","year":"2013","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616310073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616310073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:49:49Z","timestamp":1761500989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616310073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1525001616310073"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.3","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2016.3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}